Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00068770
Status:
TERMINATED
Last Update Posted:
2015-03-18
First Post:
2003-09-10
Brief Title:
Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization Data
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Class:
OTHER
Study ID:
NABTT-2100 CDR0000328117
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |